Speaker

Prof. Dr. Karin E. de Visser is senior group leader at the Division of Tumor Biology & Immunology at the Netherlands Cancer Institute, alongside her appointment as group leader at Oncode Institute and as professor of Experimental Immunobiology of Cancer at Leiden University Medical Center. She obtained her PhD in 2002 at the Division of Immunology at the Netherlands Cancer Institute in Amsterdam in the field of tumor immunotherapy. From 2003-2005 she worked as a postdoctoral fellow in the lab of Prof. dr. Lisa Coussens at the University of California, San Francisco, where she studied the interplay between the adaptive and innate immune system during cancer development. In 2005 she joined the laboratory of Prof. dr. Jos Jonkers at the Division of Molecular Biology at the Netherlands Cancer Institute, where she expanded her research direction into the field of inflammation and mammary carcinogenesis, using conditional mouse models. Currently, her research group studies the mechanisms by which the immune system influences metastatic breast cancer. Through mechanistic understanding of the crosstalk between the immune system and cancer cells she aims to contribute to the design of novel immunomodulatory strategies to fight metastatic breast cancer. Karin de Visser received an ERC consolidator grant in 2014 and a prestigious NWO-VICI grant in 2019, she is recipient of the 2015 Metastasis Research Prize of the Beug Foundation and in 2016 she was selected as a member of the EMBO young investigator program.

Homepage: https://www.nki.nl/divisions/tumor-biology-immunology/de-visser-k-group/
LinkedIn: https://www.linkedin.com/in/karin-de-visser-85b70554/

« Go Back